Cover Image

Hypoxia Enhances Oxidative Stress in Neutrophils from ZZ Alpha-1 Antitrypsin Deficiency Patients

Alpha-1 antitrypsin deficiency (AATD) is a neutrophilic inflammatory disorder that may result in local hypoxia, reactive oxygen and nitrogen species (ROS/RNS) production, and increased damage in adjacent tissues. This study aims to determine the impact of hypoxia on neutrophil oxidative stress profi...

Full description

Saved in:

Bibliographic Details
Main Authors:	María Magallón (Author), Silvia Castillo-Corullón (Author), Lucía Bañuls (Author), Daniel Pellicer (Author), Teresa Romero (Author), Carlos Martínez-Ferraro (Author), María Mercedes Navarro-García (Author), Alberto Herrejón (Author), Cruz González (Author), Francisco Dasí (Author)
Format:	Book
Published:	MDPI AG, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of Hypoxia on Neutrophil Degranulation and Inflammatory Response in Alpha-1 Antitrypsin Deficiency Patients
by: María Magallón, et al.
Published: (2024)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
by: Sabina Janciauskiene, et al.
Published: (2018)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
by: Dunlea DM, et al.
Published: (2018)

Alpha-1 Antitrypsin Deficiency: Home Therapy
by: Anna Annunziata, et al.
Published: (2021)

Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016)

Acute Disseminated Panniculitis Associated with Alpha-1 Antitrypsin Deficiency
by: António Guilherme Murinello, et al.
Published: (2022)

The spectrum of clinical sequelae associated with alpha-1 antitrypsin deficiency
by: Vickram Tejwani, et al.
Published: (2021)

Lung and liver transplantation in patients with alpha-1 antitrypsin deficiency
by: Martin R. Zamora, et al.
Published: (2021)

Imaging in alpha-1 antitrypsin deficiency: a window into the disease
by: Yuh-Chin Tony Huang, et al.
Published: (2021)

Variants of and the increasing complexity of testing for alpha-1 antitrypsin deficiency
by: Kimberly E. Foil
Published: (2021)

Cutaneous manifestation of Alpha-1 antitrypsin deficiency: A case of panniculitis
by: Sofia Lopes, et al.
Published: (2018)

COVID-19's impact on care practice for alpha-1-antitrypsin deficiency patients
by: Myriam Calle Rubio, et al.
Published: (2023)

Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives
by: Quinn M, et al.
Published: (2020)

Alpha-1-Antitrypsin Deficiency in Children-Unmet Needs Concerning the Liver Manifestation
by: Joelle Lemke, et al.
Published: (2024)

Cystic fibrosis and alpha-1 antitrypsin deficiency: case report and review of literature
by: Evi Jaspers, et al.
Published: (2022)

A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiency
by: M. Cebolla-Verdugo, et al.
Published: (2024)

Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
by: Chotirmall SH, et al.
Published: (2015)

The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Dawid Kościołek, et al.
Published: (2024)

Alpha-1 antitrypsin deficiency research and emerging treatment strategies: what's down the road?
by: Franck F. Rahaghi
Published: (2021)

Diagnosis and augmentation therapy for alpha-1 antitrypsin deficiency: current knowledge and future potential
by: Paulo Henrique Feitosa
Published: (2023)

Liver disease with unknown etiology - have you ruled out alpha-1 antitrypsin deficiency?
by: Dhiren Patel, et al.
Published: (2021)

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
by: Beiko T, et al.
Published: (2019)

Alpha 1-antitrypsin retention in an ectopic liver
by: Cathomas Gieri, et al.
Published: (2011)

A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency
by: Celine H. Chen, et al.
Published: (2024)

Zobozdravstvena vzgoja (zz-v) v mladinskem zobozdravstvu
by: Marjan Premik
Published: (1977)

Therapeutic potential of alpha-1 antitrypsin in human disease
by: Minsun Kim, et al.
Published: (2018)

Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know
by: Igor Barjaktarevic, et al.
Published: (2021)

Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature
by: Parr DG, et al.
Published: (2017)

Case Report: When cystic fibrosis, elexacaftor/tezacaftor/ivacaftor therapy, and alpha1 antitrypsin deficiency get together
by: Rachel Kinuani, et al.
Published: (2024)

Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency
by: Friedrich Kueppers, et al.
Published: (2019)

In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment
by: Shan Guan, et al.
Published: (2021)

Comparison The Activity Rate of Alpha-1 Antitrypsin in Obese with normal weight People
by: farzad roshanzamir, et al.
Published: (2014)

Decrease in alpha-1 antiproteinase antitrypsin is observed in primary Sjogren's syndrome condition
by: Brij B. Singh, et al.
Published: (2020)

Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA
by: May Hagiwara, et al.
Published: (2024)

Case report: Self-administration of alpha-1 antitrypsin therapy: a report of two cases
by: Ana M. Escribano Dueñas, et al.
Published: (2023)

Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation
by: Chengliang Yang, et al.
Published: (2020)

Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction
by: Júlia Rodríguez-Comas, et al.
Published: (2020)

Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept
by: Annalisa Bianchera, et al.
Published: (2022)

Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2
by: Nurit P Azouz, et al.
Published: (2021)

C-Terminal Alpha-1 Antitrypsin Peptide: A New Sepsis Biomarker with Immunomodulatory Function
by: Nancy Blaurock, et al.
Published: (2016)